News Releases

Jun 01, 2023
Myriad Genetics Highlights Latest Oncology Portfolio Advancements and New Data at ASCO 2023
Products
May 31, 2023
Adam Brufsky, MD, PhD, FACP Named Oncology Scientific Advisor to Myriad Genetics
Corporate
May 24, 2023
Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer
Products
May 08, 2023
Myriad Genetics Earns 2023 Great Place to Work Certification™
Corporate
May 03, 2023
Myriad Genetics Reports First Quarter 2023 Financial Results; Achieves 10% Revenue Growth Year-Over-Year, the Second Consecutive Quarter of Double-Digit Year-Over-Year Revenue Growth; Raises Mid-Point of 2023 Revenue Guidance Range
Corporate
May 02, 2023
Myriad Genetics to Participate in BofA Securities Healthcare Conference
Corporate
Apr 26, 2023
Myriad Genetics to Release First Quarter Financial Results on May 3, 2023
Financial
Apr 19, 2023
77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey
Products
Apr 18, 2023
Myriad Genetics and Intermountain Precision Genomics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification
Products
Apr 12, 2023
Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program
Products
Mar 02, 2023
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Products
Mar 01, 2023
Myriad Genetics Applauds New Expanded Carrier Screening Practice Guidelines from NSGC
Products
Feb 28, 2023
Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight® Volumes
Financial
Feb 22, 2023
Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023
Financial
Feb 09, 2023
Myriad Genetics to Participate in Upcoming Healthcare Conferences
Financial